Leslie Miller - Nov 27, 2023 Form 3 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Principal Accounting Officer
Signature
/s/ Leslie A. Miller
Stock symbol
BTTX
Transactions as of
Nov 27, 2023
Transactions value $
$0
Form type
3
Date filed
12/7/2023, 08:09 PM
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BTTX Common Stock 14.4K Nov 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BTTX Stock Option (Right to Buy) Nov 27, 2023 Common Stock 16.1K $10.97 Direct F2
holding BTTX Stock Option (Right to Buy) Nov 27, 2023 Common Stock 11.1K $1.97 Direct F3
holding BTTX Stock Option (Right to Buy) Nov 27, 2023 Common Stock 9.65K $1.14 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares represent restricted stock units (each, an "RSU") granted on April 5, 2023, which vest as to 1/2 of the shares on March 24, 2024 and the remaining shares vest on March 24, 2025, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The stock option vests as to 1/4 of the shares subject to the stock option on September 27, 2022 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.
F3 The stock option vests as to 1/4 of the shares subject to the stock option on April 1, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on April 1, 2022.
F4 The stock option vests as to 1/4 of the shares subject to the stock option on March 1, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on March 1, 2023.

Remarks:

Exhibit 24 - Power of Attorney